Trevi Therapeutics Inc (TRVI)

04:45 AM

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Given Average Rating of "Buy" by Analysts - MarketBeat

04:45 AM

Nov 22, 2025

Leerink Partnrs Has Bullish Outlook for TRVI FY2025 Earnings - MarketBeat

Nov 22, 2025

Nov 21, 2025

B. Riley Increases Earnings Estimates for Trevi Therapeutics - MarketBeat

Nov 21, 2025

Nov 20, 2025

Leerink Partners Maintains Trevi Therapeutics (TRVI) Outperform Recommendation - Nasdaq

Nov 20, 2025

Nov 20, 2025

TRVI's Price Target Raised by Leerink Partners to $16.00, Mainta - GuruFocus

Nov 20, 2025

Nov 20, 2025

What is B. Riley's Forecast for TRVI Q1 Earnings? - MarketBeat

Nov 20, 2025

Nov 20, 2025

Can Trevi Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Fed Impact & Stock Portfolio Risk Management - newser.com

Nov 20, 2025

Nov 19, 2025

Analyzing drawdowns of Trevi Therapeutics Inc. with statistical toolsBreakout Watch & Verified High Yield Trade Plans - newser.com

Nov 19, 2025

Nov 19, 2025

How resilient is Trevi Therapeutics Inc. stock in market downturns2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Leerink Partners raises Trevi Therapeutics stock price target to $16 on Haduvio outlook By Investing.com - Investing.com South Africa

Nov 19, 2025

Nov 19, 2025

Is now a turning point for Trevi Therapeutics Inc.Insider Selling & Weekly Top Gainers Trade List - newser.com

Nov 19, 2025

Nov 19, 2025

Technical signs of recovery in Trevi Therapeutics Inc.Trade Risk Report & Fast Exit/Entry Strategy Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Is Trevi Therapeutics Inc. stock a buy for dividend growthTrade Performance Summary & Safe Entry Zone Identification - newser.com

Nov 19, 2025

Nov 19, 2025

Leerink Partners raises Trevi Therapeutics stock price target to $16 on Haduvio outlook - Investing.com Canada

Nov 19, 2025

Nov 18, 2025

Should I hold or sell Trevi Therapeutics Inc. stock in 2025CEO Change & Consistent Profit Trade Alerts - newser.com

Nov 18, 2025

Nov 17, 2025

Trevi Therapeutics: Big Cough Data, Bigger Execution Risk (NASDAQ:TRVI) - Seeking Alpha

Nov 17, 2025

Nov 16, 2025

Trevi Therapeutics (NASDAQ:TRVI) Given Buy Rating at D. Boral Capital - MarketBeat

Nov 16, 2025

Nov 15, 2025

Trevi Therapeutics (NASDAQ:TRVI) Shares Gap Up Following Strong Earnings - MarketBeat

Nov 15, 2025

Nov 15, 2025

Momentum divergence signals in Trevi Therapeutics Inc. chartMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

What MACD signals say about Trevi Therapeutics Inc.July 2025 WrapUp & Entry Point Strategy Guides - newser.com

Nov 15, 2025

Nov 15, 2025

Trevi Therapeutics (TRVI): Assessing Valuation After Clinical Program Advances and Cash Runway Extension - Yahoo Finance

Nov 15, 2025

Nov 14, 2025

How Trevi Therapeutics’ (TRVI) Phase 3 Progress and Fresh Funding May Influence Investor Expectations - Yahoo Finance

Nov 14, 2025

Nov 14, 2025

Oppenheimer Maintains Trevi Therapeutics (TRVI) Outperform Recommendation - Nasdaq

Nov 14, 2025

Nov 14, 2025

Trevi Therapeutics (NASDAQ:TRVI) Posts Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat

Nov 14, 2025

Nov 14, 2025

Trevi Therapeutics (TRVI) Receives "Buy" Rating from D. Boral Ca - GuruFocus

Nov 14, 2025

Nov 14, 2025

Cantor Fitzgerald reiterates Overweight rating on Trevi Therapeutics stock By Investing.com - Investing.com Canada

Nov 14, 2025

Nov 14, 2025

Oppenheimer Raises Price Target for Trevi Therapeutics (TRVI) to $24 | TRVI Stock News - GuruFocus

Nov 14, 2025

Nov 14, 2025

Historical volatility pattern of Trevi Therapeutics Inc. visualizedMarket Sentiment Review & Long-Term Capital Growth Strategies - newser.com

Nov 14, 2025

Nov 14, 2025

Leerink Partners Begins Coverage on Trevi Therapeutics (NASDAQ:TRVI) - MarketBeat

Nov 14, 2025

Nov 14, 2025

TRVI: Morgan Stanley Raises Price Target Amid Continued Overweig - GuruFocus

Nov 14, 2025

Nov 14, 2025

Oppenheimer Adjusts Trevi Therapeutics PT to $24 From $23, Maintains Outperform Rating - MarketScreener

Nov 14, 2025

Nov 14, 2025

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025

Nov 14, 2025

Trevi Therapeutics (TRVI) Gets a Buy from Cantor Fitzgerald - The Globe and Mail

Nov 14, 2025

Nov 14, 2025

Oppenheimer raises Trevi Therapeutics stock price target on chronic cough program expansion - Investing.com Canada

Nov 14, 2025

Nov 14, 2025

Clear Street raises Trevi Therapeutics stock price target to $21 on clinical progress - Investing.com Canada

Nov 14, 2025

Nov 14, 2025

Clear Street Maintains Trevi Therapeutics (TRVI) Buy Recommendation - Nasdaq

Nov 14, 2025

Nov 14, 2025

TRVI: Analyst Maintains 'Buy' Rating and Raises Price Target | T - GuruFocus

Nov 14, 2025

Nov 14, 2025

Why retail investors pile into Trevi Therapeutics Inc. stockJuly 2025 Drop Watch & Free Real-Time Market Sentiment Alerts - Fundação Cultural do Pará

Nov 14, 2025

Nov 14, 2025

Trevi Therapeutics Inc (TRVI) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus

Nov 14, 2025

Nov 14, 2025

Decoding Trevi Therapeutics Inc (TRVI): A Strategic SWOT Insight - GuruFocus

Nov 14, 2025

Nov 14, 2025

Trevi Therapeutics Inc (TRVI) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Nov 14, 2025

Nov 14, 2025

Trevi Therapeutics Inc (TRVI) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Nov 14, 2025

Nov 13, 2025

Trevi Therapeutics Reports Q3 2025 Financials and Updates - TipRanks

Nov 13, 2025

Nov 13, 2025

Trevi Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat

Nov 13, 2025

Nov 13, 2025

Can Trevi Therapeutics Inc. stock reach $100 price target2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com

Nov 13, 2025

Nov 13, 2025

Trevi Therapeutics Trims Losses And Banks On Future Trials - Finimize

Nov 13, 2025

Nov 13, 2025

Earnings call transcript: Trevi Therapeutics reports Q3 2025 results with EPS surprise - Investing.com Australia

Nov 13, 2025